Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-26T04:31:12.690Z Has data issue: false hasContentIssue false
  • English
  • Français

A pilot study of the associations between inflammatory markers and the presence of „deficit syndrome” in schizophrenia patients

Published online by Cambridge University Press:  01 September 2022

A. Michalczyk ,
E. Tyburski ,
P. Podwalski ,
B. Misiak ,
L. Sagan  and
J. Samochowiec
A. Michalczyk*
Affiliation:
Pomeranian Medical University, Department Of Psychiatry, Szczecin, Poland
E. Tyburski
Affiliation:
Pomeranian Medical University, Department Of Psychiatry, Szczecin, Poland
P. Podwalski
Affiliation:
Pomeranian Medical University, Department Of Psychiatry, Szczecin, Poland
B. Misiak
Affiliation:
Wroclaw Medical University, Department Of Psychiatry, Wrocław, Poland
L. Sagan
Affiliation:
Pomeranian Medical University,, Department Of Neurosurgery, Szczecin, Poland
J. Samochowiec
Affiliation:
Pomeranian Medical University, Department Of Psychiatry, Szczecin, Poland
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

According to current knowledge inflammation seems to be strongly associated with pathogenesis of schizophrenia. Multiple studies and meta-analyses showed increased levels of inflammatory markers in plasma of schizophrenia patients. Individual studies have shown a relationship between the levels of inflammatory markers and the presence of deficit syndrome, but their results are inconsistent.

Objectives

Analysis of associations between inflammatory markers and the presence of deficit syndrome in schizophrenia.

Methods

Studied group consisted of 50 patients with diagnosed schizophrenia (F20) for at least 10 years, including 14 patients with deficit schizophrenia (DS) and 36 patients with non-deficit schizophrenia (NDS). DS and NDS did not differ significantly in age, BMI, duration of schizophrenia, types and doses of antipsychotics (chlorpromazine equivalent), but differed in sex (x2=4.28,p=0.039). Concentrations of inflammatory markers i.e. IL-6,IL-8,IL-10,TNFα,IFNγ,CRP were measured in serum using sensitive ELISA assays.

Results

Initial analysis showed significantly lower concentration of IL-8 in DS compared to NDS (t=-3.18,p=0.002). This association remain significant (F=7.63,p=0.0085) after co-varying for age, sex, BMI, duration of schizophrenia, type of antipsychotic medications and antipsychotics doses. Multiple logistic regression showed that female gender (OR=0.18 [0.04-0.87],p=0.034) and higher IL-8 concentrations (OR=0.03 [0.002-0.39],p=0.007) are independent predictors of lower odds of having DS.

Conclusions

Low IL-8 concentrations seem to be promising predictor of the presence of DS in schizophrenia patients, but results need further investigations. The research was funded by Polish Minister of Science and Higher Education’s program named “Regional Initiative of Excellence” in 2019–2022, grant number 002/RID/2018/2019 to the amount of 12000000PLN and by National Science Centre, Poland (2019/03/X/NZ5/00719)

Disclosure

No significant relationships.

Keywords

deficit syndromeCytokinesschizophréniainflammatory markers
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S356 - S357
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.